secwatch.observer — SEC 8-K summary
======================================

Issuer:     Corbus Pharmaceuticals Holdings, Inc. (CRBP)
CIK:        0001595097
Form:       8-K
Filed at:   2024-05-20T23:59:59+00:00
Accession:  0000950170-24-062436
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Corbus stockholders approve 2024 Equity Compensation Plan reserving 2M shares
-----------------------------------------------------------------------------

- Stockholders approved 2024 Equity Compensation Plan, reserving 2,000,000 shares of common stock for issuance under options, SARs, restricted stock, RSUs, and performance awards.
- All eight director nominees (Yuval Cohen, Alan Holmer, Avery Catlin, Rachelle Jacques, John Jenkins, Peter Salzmann, Anne Altmeyer, Yong Ben) were elected with at least 6.19M votes for each.
- Ratification of EisnerAmper LLP as independent auditor for fiscal 2024 approved with 8,388,012 votes for.
- Advisory vote on executive compensation passed with 6,593,949 votes for, 44,363 against, and 1,962,726 broker non-votes.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1595097/000095017024062436/0000950170-24-062436-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1595097/000095017024062436/crbp-20240516.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-062436

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer